MUMBAI, India, June 26 -- Intellectual Property India has published a patent application (202617066298 A) filed by Bristol-Myers Squibb Company on May 26, 2026, for Ubiquitin Specific Processing Protease 1 (usp1) Compounds.
Inventors include Meng, Wei; Paul, Anirudra; and Dhar, Murali T. G..
The application for the patent was published on June 19, 2026, under issue no. 25/2026.
Abstract: Compounds having the following formula (I) or a stereoisomer or pharmaceutically-acceptable salt thereof, where all substituents are as defined herein, are inhibitors of USP1 useful for treating diseases including, among others, treating proliferative, metabolic, allergic, autoimmune and inflammatory diseases. (Formula (I))
Disclaimer: Curated by HT Syn...